Pictet Asset Management (Switzerland)’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$112K	Buy	+14,987	New	+$112K	﹤0.01%	1840